Pediatrix Medical Group, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.9B | $2.0B | $2.0B | $2.0B | $1.9B |
| Operating income | $208.8M | -$68.7M | $7.3M | $172.7M | $202.9M |
| Operating expenses | $1.7B | $2.1B | $2.0B | $1.8B | $1.7B |
| Cash from operations | $271.1M | $206.6M | $137.3M | $166.9M | $76.7M |
| Capital expenditure | $18.5M | $22.0M | $33.3M | $29.7M | $32.2M |
| Free cash flow | $252.6M | $184.6M | $104.0M | $137.2M | $44.5M |
| Share repurchases | $86.7M | $1.7M | $919,000 | $88.5M | $4.7M |
| Impairments | — | $0 | $20.0M | $0 | $0 |
| Total assets | $2.2B | $2.2B | $2.2B | $2.3B | $2.7B |
| Total liabilities | $1.4B | $1.4B | $1.4B | $1.5B | $1.8B |
| Total debt | $596.9M | $615.6M | $628.1M | $644.6M | $1.0B |
Shares outstanding 82.1M · Free float 94.1%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.